Ibaraki, H.; Kanazawa, T.; Owada, M.; Iwaya, K.; Takashima, Y.; Seta, Y.
Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles. Pharmaceutics 2020, 12, 64.
https://doi.org/10.3390/pharmaceutics12010064
AMA Style
Ibaraki H, Kanazawa T, Owada M, Iwaya K, Takashima Y, Seta Y.
Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles. Pharmaceutics. 2020; 12(1):64.
https://doi.org/10.3390/pharmaceutics12010064
Chicago/Turabian Style
Ibaraki, Hisako, Takanori Kanazawa, Minami Owada, Keiko Iwaya, Yuuki Takashima, and Yasuo Seta.
2020. "Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles" Pharmaceutics 12, no. 1: 64.
https://doi.org/10.3390/pharmaceutics12010064
APA Style
Ibaraki, H., Kanazawa, T., Owada, M., Iwaya, K., Takashima, Y., & Seta, Y.
(2020). Anti-Metastatic Effects on Melanoma via Intravenous Administration of Anti-NF-κB siRNA Complexed with Functional Peptide-Modified Nano-Micelles. Pharmaceutics, 12(1), 64.
https://doi.org/10.3390/pharmaceutics12010064